Neomycin trisulfate salt hydrate
SIGMA/N1876 - powder
Synonym: Framycetin sulfate
CAS Number: 1405-10-3
Empirical Formula (Hill Notation): C23H46N6O13 · 3H2SO4 · xH2O
Molecular Weight: 908.88 (anhydrous basis)
EC Number: 215-773-1
Linear Formula: C23H46N6O13 · 3H2SO4 · xH2O
Product Type: Chemical
| antibiotic activity spectrum | Gram-negative bacteria |
| Gram-positive bacteria | |
| form | powder |
| InChI | 1S/C23H46N6O13.3H2O4S.H2O |
| InChI key | WHAGUNPVKDUVFV-QGTTWHFQSA |
| mode of action | protein synthesis | interferes |
| Quality Level | 200 ![]() |
| SMILES string | O.OS(O)(=O)=O.OS(O)(=O)=O |
| Application: | Neomycin Trisulfate is produced by Streptomyces containing a minimum of 85% neomycin B. It has been used as a selection agent for prokaryotic cells that have been transformed using the selectable marker gene (neo), and to study ototoxic side effects of antibiotics, platelet-derived growth factor responses in certain fibroblasts, and extraction of Nuclear Phosphatidylinositol 4,5-Bisphosphate-Interact |
| Biochem/physiol Actions: | Mode of action: This product acts by binding to the 30S and 50S subunits, causing miscoding and inhibiting initiation and elongation during protein synthesis. Neomycin also blocks voltage-sensitive Ca2+ channels without affecting the Na+/Ca2+ antiporter in neurons. Antimicrobial spectrum: Neomycin acts against both gram-positive and gram-negative bacteria. |
| General description: | Chemical structure: aminoglycoside |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place.Keep in a dry place |
| Packaging: | 25, 100 g in glass bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H317 - H334 |
| Precautionary statements | P261 - P280 - P342 + P311 |
| Hazard Codes | Xn |
| Risk Statements | 42/43 |
| Safety Statements | 22-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 51101500 |


